Novel tetrahydronaphthalen-1-yl-phenethyl ureas: synthesis and dual antibacterial-anticancer activities

References

• Zhang Y, Anderson M, Weisman JL, Lu M, Choy CJ, Boyd VA, Price J, Sigal M, Clark J, Connelly M, et al. Evaluation of diarylureas for activity against Plasmodium falciparum. ACS Med Chem Lett. 2010;1(9):460–465.
   PubMed Web of Science ®Google Scholar
• Paget CJ, Kisner K, Stone RL, DeLong DC. Heterocyclic substituted ureas. II. Immunosuppressive and antiviral activity of benzothiazolyl- and benzoxazolylureas. J Med Chem. 1969;12(6):1016–1018.
   PubMedGoogle Scholar
• Schroeder MC, Hamby JM, Connolly CJ, Grohar PJ, Winters RT, Barvian MR, Moore CW, Boushelle SL, Crean SM, Kraker AJ, et al. Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure–activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activity. J Med Chem. 2001;44(12):1915–1926.
   PubMed Web of Science ®Google Scholar
• Wróbel TM, Kiełbus M, Kaczor AA, Kryštof V, Karczmarzyk Z, Wysocki W, Fruziński A, Król SK, Grabarska A, Stepulak A, et al. Discovery of nitroaryl urea derivatives with antiproliferative properties. J Enzyme Inhib Med Chem. 2016;31(4):608–618.
   PubMed Web of Science ®Google Scholar
• North EJ, Scherman MS, Bruhn DF, Scarborough JS, Maddox MM, Jones V, Grzegorzewicz A, Yang L, Hess T, Morisseau C, et al. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties. Bioorg Med Chem. 2013;21(9):2587–2599.
   PubMed Web of Science ®Google Scholar
• Pandurangan K, Kitchen JA, Blasco S, Paradisi F, Gunnlaugsson T. Supramolecular pyridyl urea gels as soft matter with antibacterial properties against MRSA and/or E. coli. Chem Commun. 2014;50(74):10819–10822.
   PubMed Web of Science ®Google Scholar
• Hofmann C, Penner U, Dorow R, Pertz HH, Jähnichen S, Horowski R, Latté KP, Palla D, Schurad B. Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis. Clin Neuropharmacol. 2006;29(2):80–86.
   PubMed Web of Science ®Google Scholar
• Reichmann H. Long-term treatment with dopamine agonists in idiopathic in Parkinson’s disease. J Neurol. 2000;247(4):IV17–IV19.
   Google Scholar
• Zeldin RK, Petruschke RA. Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. J Antimicrob Chemother. 2004;53(1):4–9.
   PubMed Web of Science ®Google Scholar
• Igwe KK, Ikpeazu OV, Otuokere IE, Department of Veterinary Biochemistry and Animal Production, Michael Okpara University of Agriculture, Umudike, Nigeria. Global energy and molecular interactions between pazopanib, axitinib and sorafenib anticancer drugs with vascular endothelial growth factor. J Biosci Biotechnol Discov. 2017;2(4):91–96.
   Google Scholar
• Matsui J, Funahashi Y, Uenaka T, Watanabe T, Tsuruoka A, Asada M. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin Cancer Res. 2008;14(17):5459–5465.
   PubMed Web of Science ®Google Scholar
• Sabelli HC, Mosnaim AD, Vazquez AJ, Giardina WJ, Borison RL, Pedemonte WA. Biochemical plasticity of synaptic transmission: a critical review of Dale’s principle. Biol Psychiatry. 1976;11(4):481–524.
   PubMed Web of Science ®Google Scholar
• Finberg JPM, Gillman K. Selective inhibitors of monoamine oxidase type B and the “cheese effect”. Int Rev Neurobiol. 2011;100:169–190.
   PubMed Web of Science ®Google Scholar
• Carlsson A. Biochemical and pharmacological aspects of Parkinsonism. Acta Neurol Scand Suppl. 1972;51:11–42.
   PubMedGoogle Scholar
• Bredikhina ZA, Kurenkov AV, Krivolapov DB, Bredikhin AA. Synthesis of all of the stereoisomers of β3-adrenoceptor antagonist SR 59230 based on the spontaneous resolution of 3-(2-ethylphenoxy) propane-1,2-diol. Tetrahedron Asymmetry. 2016;27(11–12):467–474.
   Google Scholar
• Welch WM, Kraska AR, Sarges R, Koe BK. Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins. J Med Chem. 1984;27(11):1508–1515.
   PubMed Web of Science ®Google Scholar
• Akbaba Y, Kacı FN, Göksu S. Substituted tetrahydronaphthalen‐1‐yl‐phenethyl ureas: synthesis, characterization, and biological evaluations. ChemistrySelect. 2022;7(15):e202200450.
   Web of Science ®Google Scholar
• Özgeriş B, Akbaba Y, Özdemir Ö, Türkez H, Göksu S. Synthesis and anticancer activity of novel ureas and sulfamides incorporating 1-aminotetralins. Arch Med Res. 2017;48(6):513–519.
   PubMed Web of Science ®Google Scholar
• Gormez A, Bozari S, Yanmis D, Gulluce M, Sahin F, Agar G. Chemical composition and antibacterial activity of essential oils of two species of Lamiaceae against phytopathogenic bacteria. Pol J Microbiol. 2015;64(2):121–127.
   PubMed Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163–175.
   PubMed Web of Science ®Google Scholar
• Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 1997;44(7):1299–1305.
   PubMed Web of Science ®Google Scholar
• Koch A, Tamez P, Pezzuto J, Soejarto D. Evaluation of plants used for antimalarial treatment by the Maasai of Kenya. J Ethnopharmacol. 2005;101(1–3):95–99.
   PubMed Web of Science ®Google Scholar
• Yang C, Tan J, Zhu J, Wang S, Wei G. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma. Oncotarget. 2017;8(23):37154–37163.
   PubMedGoogle Scholar
• Sasaki-Kudoh E, Kudo I, Kakizaki Y, Hosaka M, Ikeda S-I, Uemura S, Grave E, Togashi S, Sugawara T, Shimizu H, et al. Cisplatin inhibits AhR activation. Am J Mol Biol. 2018;8(1):69–82.
   Google Scholar
• Czarnomysy R, Bielawski K, Muszynska A, Bielawska A, Gornowicz A. Biological evaluation of dimethylpyridine–platinum complexes with potent antiproliferative activity. J Enzyme Inhib Med Chem. 2016;31(Suppl. 3):150–165.
   PubMedGoogle Scholar
• Mphahlele MJ, Gildenhuys S, Parbhoo N. Synthesis, cytotoxicity and molecular docking studies of the 9-substituted 5-styryltetrazolo [1, 5-c]quinazoline derivatives. Molecules. 2017;22(11):1719.
   PubMed Web of Science ®Google Scholar
• Xu H, Cheung IY, Wei XX, Tran H, Gao X, Cheung NV. Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G 1 checkpoint-defective neuroblastoma. Int J Cancer. 2011;129(8):1953–1962.
   PubMed Web of Science ®Google Scholar
• Shao JW, Dai YC, Xue JP, Wang JC, Lin FP, Guo YH. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives. Eur J Med Chem. 2011;46(7):2652–2661.
   PubMed Web of Science ®Google Scholar
• Zargan J, Sajad M, Umar S, Naime M, Ali S, Khan HA. Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest. Exp Mol Pathol. 2011;91(1):447–454.
   PubMed Web of Science ®Google Scholar
• Özgeriş B. Synthesis of substituted phenethylamine-based thioureas and their antimicrobial and antioxidant properties. Russ J Org Chem. 2021;57(3):422–429.
   Web of Science ®Google Scholar
• Suffness M, Pezzuto JM. Assays related to cancer drug discovery. In: Hostettmann, editor. Methods in plant biochemistry: assays for bioactivity. Vol. 6. London (UK): Academic Press; 1990. p. 71–133.
   Google Scholar
• McMorris TC, Chimmani R, Alisala K, Staake MD, Banda G, Kelner MJ. Structure–activity studies of urea, carbamate, and sulfonamide derivatives of acylfulvene. J Med Chem. 2010;53(3):1109–1116.
   PubMed Web of Science ®Google Scholar
• Duspara PA, Islam MS, Lough AJ, Batey RA. Synthesis and reactivity of N-alkyl carbamoylimidazoles: development of N-methyl carbamoylimidazole as a methyl isocyanate equivalent. J Org Chem. 2012;77(22):10362–10368.
   PubMed Web of Science ®Google Scholar
• Grzyb JA, Shen M, Yoshina-Ishii C, Chi W, Brown RS, Batey RA. Carbamoylimidazolium and thiocarbamoylimidazolium salts: novel reagents for the synthesis of ureas, thioureas, carbamates, thiocarbamates and amides. Tetrahedron. 2005;61(30):7153–7175.
   Web of Science ®Google Scholar
• Tundo P, Selva M. The chemistry of dimethyl carbonate. Acc Chem Res. 2002;35(9):706–716.
   PubMed Web of Science ®Google Scholar
• Diaz DJ, Darko AK, McElwee‐White L. Transition metal‐catalyzed oxidative carbonylation of amines to ureas. Eur J Org Chem. 2007;2007(27):4453–4465.
   Web of Science ®Google Scholar
• Ready JM, Nijhawan D, Gonzales SS, Theodoropoulos P. Preparation of benzothiophenes and other compounds and methods and compositions for selective and targeted cancer therapy. PCT Int Appl. 2015; WO2015035051A1. 307 pp.
   Google Scholar
• Eckert H, Forster B. Triphosgene, a crystalline phosgene substitute. Angew Chem Int Ed Engl. 1987;26(9):894–895.
   Web of Science ®Google Scholar
• Shi H, Hu W, Sun Y. Preparation of chloroformates using bis(trichloromethyl)carbonate. J Chem Res. 2004;2004(10):708–709.
   Google Scholar
• Rose TE, Morisseau C, Liu J-Y, Inceoglu B, Jones PD, Sanborn JR, Hammock BD. 1-Aryl-3-(1-acylpiperidin-4-yl) urea inhibitors of human and murine soluble epoxide hydrolase: structure–activity relationships, pharmacokinetics, and reduction of inflammatory pain. J Med Chem. 2010;53(19):7067–7075.
   PubMed Web of Science ®Google Scholar
• Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–3484.
   PubMed Web of Science ®Google Scholar
• Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK, Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011.
   PubMed Web of Science ®Google Scholar
• Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–318.
   PubMed Web of Science ®Google Scholar
• Rauf MK, Talib A, Badshah A, Zaib S, Shoaib K, Shahid M, Flörke U, Imtiaz-Ud-Din Iqbal J. Solution-phase microwave assisted parallel synthesis of N,N′-disubstituted thioureas derived from benzoic acid: biological evaluation and molecular docking studies. Eur J Med Chem. 2013;70:487–496.
   PubMed Web of Science ®Google Scholar
• Obradović D, Nikolić S, Milenković I, Milenković M, Jovanović P, Savić V, Roller A, Đorđić Crnogorac M, Stanojković T, Grgurić-Šipka S, et al. Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru (II) arene complexes with benzoylthiourea derivatives. J Inorg Biochem. 2020;210:111164.
   PubMed Web of Science ®Google Scholar
• Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Ceña V, Gallego C, Comella JX. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem. 2000;75(3):991–1003.
   PubMed Web of Science ®Google Scholar
• Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002;2(4):315–319.
   PubMed Web of Science ®Google Scholar
• Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry. 1991;30(18):4480–4486.
   PubMed Web of Science ®Google Scholar
• Abdelhaleem EF, Abdelhameid MK, Kassab AE, Kandeel MM. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7. Eur J Med Chem. 2018;143:1807–1825.
   PubMed Web of Science ®Google Scholar
• Esteves-Souza A, Pissinate K, Graça Nascimento MD, Grynberg NF, Echevarria A. Synthesis, cytotoxicity, and DNA-topoisomerase inhibitory activity of new asymmetric ureas and thioureas. Bioorg Med Chem. 2006;14(2):492–499.
   PubMed Web of Science ®Google Scholar
• Charifson PS, Grillot A-L, Grossman TH, Parsons JD, Badia M, Bellon S, Deininger DD, Drumm JE, Gross CH, LeTiran A, et al. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure–activity relationships. J Med Chem. 2008;51(17):5243–5263.
   PubMed Web of Science ®Google Scholar
• Alfonso EE, Deng Z, Boaretto D, Hood BL, Vasile S, Smith LH, Chambers JW, Chapagain P, Leng F. Novel and structurally diversified bacterial DNA gyrase inhibitors discovered through a fluorescence-based high-throughput screening assay. ACS Pharmacol Transl Sci. 2022;5(10):932–944.
   PubMedGoogle Scholar
• Kundu D, Zhu A, Kim E, Paudel S, Jang C-G, Lee YS, Kim K-M. Potential functional role of phenethylamine derivatives in inhibiting dopamine reuptake: structure–activity relationship. Biomol Ther. 2023;31(1):108–115.
   PubMedGoogle Scholar
• Khan T, Sankhe K. DNA gyrase inhibitors. In: Offermanns, editor. Encyclopedia of molecular pharmacology. Cham: Springer International Publishing; 2021. p. 1–8.
   Google Scholar
• Dighe SN, Collet TA. Recent advances in DNA gyrase-targeted antimicrobial agents. Eur J Med Chem. 2020;199:112326.
   PubMed Web of Science ®Google Scholar
• Morgan H, Lipka-Lloyd M, Warren AJ, Hughes N, Holmes J, Burton NP, Mahenthiralingam E, Bax BD. A 2.8 Å structure of zoliflodacin in a DNA cleavage complex with Staphylococcus aureus DNA gyrase. Int J Mol Sci. 2023;24(2):1634.
   PubMed Web of Science ®Google Scholar
• Shyian M, Shore D. Approaching protein barriers: emerging mechanisms of replication pausing in eukaryotes. Front Cell Dev Biol. 2021;9:672510.
   PubMed Web of Science ®Google Scholar
• Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009;9(5):338–350.
   PubMed Web of Science ®Google Scholar
• Francisco GD, Li Z, Albright JD, Eudy NH, Katz AH, Petersen PJ, Labthavikul P, Singh G, Yang Y, Rasmussen BA, et al. Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis. Bioorg Med Chem Lett. 2004;14(1):235–238.
   PubMed Web of Science ®Google Scholar
• Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med. 1994;331(14):904–909.
   PubMed Web of Science ®Google Scholar
• Molinoff PB, Axelrod J. Biochemistry of catecholamines. Annu Rev Biochem. 1971;40(1):465–500.
   PubMedGoogle Scholar